U.S. FDA advisers to discuss second COVID vaccine boosters in April

A panel of independent advisers to the U.S. Food and Drug Administration is set to meet on April 6 to discuss considerations for use of COVID-19 vaccine booster doses from Pfizer Inc and Moderna Inc. The panel will also discuss the process for selecting COVID-19 vaccine strain to address current and emerging variants, the U.S. FDA said.